BC
AVNS

Burleson & Co’s Avanos Medical AVNS Stock Holding History

Burleson & Co’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$3.38K Hold
125
– – ﹤0.01% 318
2022
Q3 		$3K Hold
125
– – ﹤0.01% 327
2022
Q2 		$3K Hold
125
– – ﹤0.01% 312
2022
Q1 		$4K Hold
125
– – ﹤0.01% 308
2021
Q4 		$4K Hold
125
– – ﹤0.01% 297
2021
Q3 		$4K Hold
125
– – ﹤0.01% 290
2021
Q2 		$5K Hold
125
– – ﹤0.01% 291
2021
Q1 		$5K Buy
+125
New +$5.87K ﹤0.01% 280

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Burleson & Co's AVNS Position: Q4 2022 in Review

Burleson & Co held its Avanos Medical (AVNS) position steady in Q4 2022 at 125 shares worth $3.38K. The position accounts for ﹤0.01% of the portfolio, ranked #318.

Burleson & Co first reported a position in AVNS in Q1 2021 and has held it in 8 quarters since. The position peaked at $5K in Q2 2021. 288 funds tracked by Wall St. Rank hold AVNS as of Q4 2022.

  • Burleson & Co held 125 shares of Avanos Medical worth $3.38K as of Q4 2022.
  • Burleson & Co left its Avanos Medical share count unchanged in Q4 2022.
  • Avanos Medical made up ﹤0.01% of Burleson & Co's portfolio in Q4 2022, its #318 holding.
  • Burleson & Co first reported a position in Avanos Medical in Q1 2021 and has held it in 8 quarters since.
  • Burleson & Co's Avanos Medical position peaked at $5K in Q2 2021.
  • 288 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2022.

Based on Burleson & Co's 13F filing for Q4 2022, filed 31 Jan 2023.